BioInsights - Webinars

IMMUNO-ONCOLOGY INSIGHTS

On demand webinars

Mononuclear phagocytes in tissue: from inflammation to cancer

Mononuclear phagocytes in tissue: from inflammation to cancer

Egle Kvedaraite
24 May 2023
Watch
Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

Stephan Wilmes
23 May 2023
Watch
Cell profiling and biomarker discovery in a spatial context: a guide to analyzing your spatial biology data for immuno-oncology applications

Cell profiling and biomarker discovery in a spatial context: a guide to analyzing your spatial biology data for immuno-oncology applications

Telma Santos
17 May 2023
Watch
Spatial biology out of the box: a pre-defined antibody panel for TME phenotyping of solid tumors

Spatial biology out of the box: a pre-defined antibody panel for TME phenotyping of solid tumors

Amy Jablonski
10 May 2023
Watch
Spatial biology at its best – a complete workflow solution to advance immuno-oncology

Spatial biology at its best – a complete workflow solution to advance immuno-oncology

Jenia Schlegel, Sara Rahmati
3 May 2023
Watch
Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Large-scale genome editing of primary human natural killer (NK) cells: A quest toward manufacture of clinically relevant CAR NK cells

Deepak Kumar
20 April 2023
Watch
Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Next-generation CRISPR mRNA-LNPs and scale up manufacturing for CAR T cells

Reka Geczy, Bernice Thommandru
23 March 2023
Watch
Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F. Boj, Andrea Bisso
2 March 2023
Watch
Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

Assessing efficacy and MoA of mono and combo immunotherapies in preclinical humanized models

D Thiam, D van der Horst, D Surya
18 January 2023
Watch
The CAR toolkit: progress and challenges in CAR T/NK cell R&D and manufacture

The CAR toolkit: progress and challenges in CAR T/NK cell R&D and manufacture

H Dhamne, T Manning, S Steiner
7 December 2022
Watch
Modulation of both tumor and T cell apoptosis to enhance CART immunotherapy

Modulation of both tumor and T cell apoptosis to enhance CART immunotherapy

Marco Ruella
26 October 2022
Watch
Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

Circulating tumor DNA as a predictive biomarker for immunotherapy response: from clinical trials to clinical practice

M Krainock, A Tan, J Simmons
19 October 2022
Watch
Manufacturing GMP-compliant iPSCs in closed and open systems

Manufacturing GMP-compliant iPSCs in closed and open systems

Dr. Dhruv Sareen, Dr. Chao Sheng
18 October 2022
Watch
Predicting patient response to immune targeted therapies via interrogation of the TME

Predicting patient response to immune targeted therapies via interrogation of the TME

Dr Caroline Fong
12 October 2022
Watch
Feeder free expansion and closed wash and concentration of a clinically relevant number of human NK cells

Feeder free expansion and closed wash and concentration of a clinically relevant number of human NK cells

Erica Heipertz, PhD
29 September 2022
Watch
Manufacturing of NK cells for the clinic: the Spanish experience

Manufacturing of NK cells for the clinic: the Spanish experience

Antonio Perez-Martinez
27 September 2022
Watch
Accelerating immuno-oncology innovation using humanized mouse models

Accelerating immuno-oncology innovation using humanized mouse models

Santi Suryani Chen, PhD.
21 September 2022
Watch
Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Transient expression of mRNA lipid nanoparticle-based chimeric antigen receptors for safe immunotherapy

Sandy Tretbar
6 July 2022
Watch
Thinking translational: Things to consider in CAR T cell research workflows

Thinking translational: Things to consider in CAR T cell research workflows

Saskia Rösch, PhD
22 June 2022
Watch
Accelerating cell therapy discovery & development with non-viral gene engineering

Accelerating cell therapy discovery & development with non-viral gene engineering

D Hermanson, X Patrinostro, S Silaika
16 June 2022
Watch
Overcoming current challenges in immunotherapy drug development with patient-derived organoids

Overcoming current challenges in immunotherapy drug development with patient-derived organoids

15 June 2022
Watch
Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Life on a chip - vascularized micro-tumor chips for mimicking clinical drug responses

Chris Hughes
8 June 2022
Watch
Monitoring of circulating CAR T cells

Monitoring of circulating CAR T cells

A Graband, D Hünecke, D Bremm
31 May 2022
Watch
Enabling clinical grade manufacturing of gene-engineered NK cells

Enabling clinical grade manufacturing of gene-engineered NK cells

N Möker, P Evelyn Ullrich, R MD et al.
30 November 2021
Watch
Advancing engineered cell and gene therapy with precision gene editing

Advancing engineered cell and gene therapy with precision gene editing

Danilo Maddalo
11 November 2021
Watch
Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis

Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis

D Souders, T PhD, N Bevan et al.
6 October 2021
Watch
The therapeutic gene editing solution – cell therapy for solid tumors

The therapeutic gene editing solution – cell therapy for solid tumors

B PhD, P PhD, J PhD et al.
30 September 2021
Watch
Get your non-viral T cell engineering process ready for clinical manufacturing

Get your non-viral T cell engineering process ready for clinical manufacturing

M Rietenbach, S Wild, K Patel
21 September 2021
Watch
Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

N Ph.D., P Fan, T Laskowski, Ph.D.
5 August 2021
Watch
Accelerating CAR-T process development: The power of process insight

Accelerating CAR-T process development: The power of process insight

Julia Hupfeld, Ph.D.
29 July 2021
Watch
Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Y Ji, S PhD, N PhD
29 June 2021
Watch
Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Laurens Sierkstra
10 June 2021
Watch
Protein biomarkers in plasma: revealing biological insights into the tumor microenvironment

Protein biomarkers in plasma: revealing biological insights into the tumor microenvironment

Dr Genevieve Boland, Dr Arnav Mehta
20 May 2021
Watch
Ultrahigh-content imaging helps to identify CAR target candidates against pancreatic adenocarcinoma

Ultrahigh-content imaging helps to identify CAR target candidates against pancreatic adenocarcinoma

Dr. Daniel Schäfer
20 April 2021
Watch
Navigating current translational challenges in establishing clinical CAR T cell therapy manufacture

Navigating current translational challenges in establishing clinical CAR T cell therapy manufacture

D García Guerreiro, D Kassim, D Dudley et al.
7 April 2021
Watch
Studying solid tumors and their micro-environment based on automated large-scale 3D fluorescence imaging

Studying solid tumors and their micro-environment based on automated large-scale 3D fluorescence imaging

Nizar Yousif, Hussein Hamzeh
25 March 2021
Watch
Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

D Pelletier, F PhD, N Monhasery
3 March 2021
Watch
Focus on allogeneic CAR-Ts manufacturing challenges and solutions

Focus on allogeneic CAR-Ts manufacturing challenges and solutions

M Langtry, A Sargent, B Baghbaderani
5 November 2020
Watch
Evolving the role of gene editing in cell therapy

Evolving the role of gene editing in cell therapy

J Frampton, T Thwaites, T Meissner
6 October 2020
Watch
The multi-modal manufacturing movement - you don't need to know the future to be ready for it

The multi-modal manufacturing movement - you don't need to know the future to be ready for it

Peter Walters, Noel Maestre
30 September 2020
Watch
Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics

Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics

Patrick Ott, Ilse Roodink
23 September 2020
Watch
Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets

Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets

Ali Mohamed, Megan Ciarlo
14 July 2020
Watch
Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes

Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes

M Luevano, X Wang, S Fricke et al.
9 June 2020
Watch
Gaining critical characterization insights for development of CAR-T therapies for solid tumors

Gaining critical characterization insights for development of CAR-T therapies for solid tumors

John O’Rourke, Janani Krishnamurthy
16 May 2019
Watch